What Percentage of Premature Babies Develop Retinopathy of Prematurity Requiring Treatment?

How Do NICU Data Trends and Birth Weight Predict ROP Risk?

The risk of ROP is inversely proportional to birth weight and gestational age. Babies born before twenty-eight weeks or weighing less than 750 grams are in the highest risk category, with nearly 90 percent showing some sign of the disease. In the NICU, the careful management of oxygen levels is critical, as too much oxygen can trigger the growth of the abnormal, leaky blood vessels that define ROP. Advances in neonatal care have significantly improved the survival rates of these "micro-preemies," but this has also increased the number of infants requiring ROP screening.

What are the Severity Stages and the "Plus Disease" Warning Sign?

ROP is categorized into five stages, with Stage 1 being a mild line between the normal and abnormal retina and Stage 5 being a total retinal detachment. The most critical warning sign for a pediatric ophthalmologist is "Plus Disease," where the blood vessels in the back of the eye become extremely dilated and twisted. The presence of Plus Disease indicates that the condition is progressing rapidly and that the baby is at immediate risk for vision loss. Identifying this transition early is the key to timing the treatment successfully.

How Does Laser and Anti-VEGF Therapy Save Infant Vision?

Treatment for severe ROP has evolved from traditional freezing (cryotherapy) to modern laser and injection therapies. Laser photocoagulation is used to "seal" the peripheral retina, which stops the production of growth factors that drive the abnormal vessels. Alternatively, injections of anti-VEGF medications can be used to chemically block these growth factors, allowing the vessels to regress without the permanent peripheral vision loss caused by the laser. Both treatments have a success rate of over 90 percent in preventing retinal detachment if performed within the narrow treatment window.

What are the Long-Term Vision Consequences for ROP Survivors?

Even when treatment is successful, ROP survivors face a lifetime of higher visual risks. Approximately 30 percent of children with a history of ROP develop high myopia (severe nearsightedness) or strabismus (crossed eyes) by age five. There is also a significantly higher risk of late-onset retinal detachment in their teenage years or early adulthood. Lifelong follow-up with a pediatric eye specialist is mandatory to manage these secondary issues and ensure the child reaches their full visual potential.

Why is the Screening Schedule Mandatory for High-Risk Infants?

ROP screening is not optional; it is a rigid medical requirement for any infant born at or before thirty weeks or weighing less than 1500 grams. The first exam typically occurs four weeks after birth, with follow-ups every one to two weeks until the retinal vessels reach the edge of the eye. Missing even a single exam can be catastrophic, as the disease can move from a treatable stage to a total detachment in just a few days. Parental education and coordination between the NICU and eye specialists are the most important factors in preventing ROP blindness.